Chunya Lu

611 total citations
18 papers, 386 citations indexed

About

Chunya Lu is a scholar working on Molecular Biology, Cancer Research and Infectious Diseases. According to data from OpenAlex, Chunya Lu has authored 18 papers receiving a total of 386 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Cancer Research and 3 papers in Infectious Diseases. Recurrent topics in Chunya Lu's work include MicroRNA in disease regulation (6 papers), Cancer-related molecular mechanisms research (6 papers) and RNA modifications and cancer (3 papers). Chunya Lu is often cited by papers focused on MicroRNA in disease regulation (6 papers), Cancer-related molecular mechanisms research (6 papers) and RNA modifications and cancer (3 papers). Chunya Lu collaborates with scholars based in China, United States and Switzerland. Chunya Lu's co-authors include Guojun Zhang, Huaqi Wang, Rui Yang, Guoqiang Zhao, Ruirui Cheng, Shanshan Chen, Hui Li, Furui Zhang, Ping Li and Li Wang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Nature Structural & Molecular Biology and Frontiers in Immunology.

In The Last Decade

Chunya Lu

18 papers receiving 383 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chunya Lu China	10	266	165	59	39	34	18	386
Kaiyin Yang China	11	302 1.1×	141 0.9×	103 1.7×	71 1.8×	22 0.6×	13	503
Huanyu Zhang China	8	191 0.7×	133 0.8×	43 0.7×	84 2.2×	21 0.6×	13	380
Amirhossein Sheida Iran	11	253 1.0×	181 1.1×	56 0.9×	23 0.6×	9 0.3×	17	395
Muhammad Hasan Bashari Indonesia	11	133 0.5×	43 0.3×	44 0.7×	60 1.5×	22 0.6×	51	320
Hong‐Rae Kim South Korea	10	198 0.7×	39 0.2×	54 0.9×	36 0.9×	13 0.4×	33	350
Simone Fuchs Germany	7	152 0.6×	54 0.3×	33 0.6×	66 1.7×	24 0.7×	8	303
Ahmad Iskandarani Qatar	13	208 0.8×	98 0.6×	11 0.2×	39 1.0×	8 0.2×	19	366
Sarita Montaño Mexico	11	168 0.6×	76 0.5×	72 1.2×	29 0.7×	4 0.1×	29	330
Saisai Guo China	11	127 0.5×	42 0.3×	98 1.7×	29 0.7×	14 0.4×	18	290
Qijia Yu China	7	242 0.9×	90 0.5×	26 0.4×	96 2.5×	11 0.3×	9	394

Countries citing papers authored by Chunya Lu

Since Specialization

Citations

This map shows the geographic impact of Chunya Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chunya Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chunya Lu more than expected).

Fields of papers citing papers by Chunya Lu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chunya Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chunya Lu. The network helps show where Chunya Lu may publish in the future.

Co-authorship network of co-authors of Chunya Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Chunya Lu. A scholar is included among the top collaborators of Chunya Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chunya Lu. Chunya Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Ren, Yuqing, Chunya Lu, Nan Jiang, et al.. (2025). The research progress on meningeal metastasis in solid tumors. Discover Oncology. 16(1). 254–254. 2 indexed citations

Yue, Yi, et al.. (2024). Epigenetic regulation of human FOXP3+ Tregs: from homeostasis maintenance to pathogen defense. Frontiers in Immunology. 15. 1444533–1444533. 12 indexed citations

Lu, Chunya, Hongxia Jia, Shanshan Chen, et al.. (2024). SULF1 expression is increased and promotes fibrosis through the TGF-β1/SMAD pathway in idiopathic pulmonary fibrosis. Journal of Translational Medicine. 22(1). 885–885. 2 indexed citations

Chen, Shanshan, Ronghao Sun, Chunya Lu, et al.. (2023). Anlotinib prove to be a potential therapy for the treatment of pulmonary fibrosis complicated with lung adenocarcinoma. Pulmonary Pharmacology & Therapeutics. 80. 102202–102202. 3 indexed citations

Lu, Chunya, et al.. (2023). Long non-coding RNA DSCAS regulates cisplatin sensitivity in lung squamous cell carcinoma by competitively binding to miR-646-3p. Heliyon. 9(6). e16865–e16865. 2 indexed citations

Wang, Xinjuan, Hongxia Jia, Hongping Liu, et al.. (2023). [Evaluation of Efficacy and Prognosis Analysis of Stage III-IV SMARCA4-deficient  Non-small Cell Lung Cancer Treated by PD-1 Immune Checkpoint Inhibitors plus  Chemotherapy and Chemotherapy].. SHILAP Revista de lepidopterología. 26(9). 659–668. 2 indexed citations

Mysore, Venkatesh, Zhi-Wei Zhou, Chiara Ambrogio, et al.. (2021). A structural model of a Ras–Raf signalosome. Nature Structural & Molecular Biology. 28(10). 847–857. 44 indexed citations

Lu, Xinhua, Chenyang Xu, Chunya Lu, et al.. (2021). Piperlongumine inhibits the growth of non-small cell lung cancer cells via the miR-34b-3p/TGFBR1 pathway. BMC Complementary Medicine and Therapies. 21(1). 15–15. 16 indexed citations

Wang, Huaqi, Yunfei Wang, Chunya Lu, et al.. (2021). The efficacy of probiotics in patients with severe COVID-19. Annals of Palliative Medicine. 10(12). 12374–12380. 22 indexed citations

10.

Zhang, Furui, et al.. (2021). Hsa_circ_0010235 functions as an oncogenic drive in non-small cell lung cancer by modulating miR-433-3p/TIPRL axis. Cancer Cell International. 21(1). 73–73. 34 indexed citations

11.

Bera, Asim K., Jia Lu, Chunya Lu, et al.. (2020). GTP hydrolysis is modulated by Arg34 in the RASopathy‐associated KRAS^P34R. Birth Defects Research. 112(10). 708–717. 5 indexed citations

12.

Chen, Shanshan, Chunya Lu, Ping Li, et al.. (2020). [Effectiveness of convalescent plasma for treatment of coronavirus disease 2019 patients].. PubMed. 32(11). 1293–1298. 3 indexed citations

13.

Zhang, Guojun, et al.. (2020). [Epidemiological characteristics of novel coronavirus pneumonia in Henan].. PubMed. 43(4). 327–331. 48 indexed citations

14.

Wu, Shujun, Hui Li, Chunya Lu, et al.. (2018). Aberrant expression of hsa_circ_0025036 in lung adenocarcinoma and its potential roles in regulating cell proliferation and apoptosis. Biological Chemistry. 399(12). 1457–1467. 15 indexed citations

15.

Lu, Chunya, Huaqi Wang, Shanshan Chen, et al.. (2018). Baicalein inhibits cell growth and increases cisplatin sensitivity of A549 and H460 cells via miR‐424‐3p and targeting PTEN/PI3K/Akt pathway. Journal of Cellular and Molecular Medicine. 22(4). 2478–2487. 70 indexed citations

16.

Zhang, Guowei, Hao Zheng, Guojun Zhang, et al.. (2017). MicroRNA-338-3p suppresses cell proliferation and induces apoptosis of non-small-cell lung cancer by targeting sphingosine kinase 2. Cancer Cell International. 17(1). 46–46. 42 indexed citations

17.

Wang, Huaqi, Li Wang, Guojun Zhang, et al.. (2017). MALAT1/miR-101-3p/MCL1 axis mediates cisplatin resistance in lung cancer. Oncotarget. 9(7). 7501–7512. 55 indexed citations

18.

Bai, Yong, Chunya Lu, Guojun Zhang, et al.. (2017). Overexpression of miR-519d in lung adenocarcinoma inhibits cell proliferation and invasion via the association of eIF4H. Tumor Biology. 39(3). 3726131056–3726131056. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact